Alternative approach to express Mycobacterium tuberculosis proteins in Escherichia coliMUKHERJEE, Sandeep; DAIFALLA, Nada; CHAO LIU et al.BioTechniques. 2003, Vol 35, Num 1, pp 34-40, issn 0736-6205, 4 p.Article

IL-12Rβ2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune responseCHAKIR, Habiba; CAMPOS-NETO, Antonio; MOJIBIAN, Majid et al.Microbes and infection. 2003, Vol 5, Num 4, pp 241-249, issn 1286-4579, 9 p.Article

Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalisSTASHENKO, Philip; GONCALVES, Reginaldo B; LIPKIN, Brad et al.The American journal of pathology. 2007, Vol 170, Num 1, pp 203-213, issn 0002-9440, 11 p.Article

Guinea pig model of Mycobacterium tuberculosis latent/dormant infectionKASHINO, Suely S; NAPOLITANO, Danielle R; SKOBE, Ziedonis et al.Microbes and infection. 2008, Vol 10, Num 14-15, pp 1469-1476, issn 1286-4579, 8 p.Article

An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infectionCAYABYAB, Mark J; LIZENG QIN; KASHINO, Suely S et al.Vaccine. 2013, Vol 31, Num 42, pp 4834-4840, issn 0264-410X, 7 p.Article

Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigsREECE, Stephen T; STRIDE, Nicole; OVENDALE, Pamela et al.Infection and immunity. 2005, Vol 73, Num 6, pp 3301-3306, issn 0019-9567, 6 p.Article

Cross-sectional and Longitudinal Epidemiologic Surveys of Human and Canine Leishmania infantum Visceral Infections in an Endemic Rural Area of Southeast Brazil (Pancas, Espfrito Santo)FALQUETO, Aloisio; FERREIRA, Adelson L; DOS SANTOS, Claudiney B et al.The American journal of tropical medicine and hygiene. 2009, Vol 80, Num 4, pp 559-565, issn 0002-9637, 7 p.Article

Evaluation of the Effect of Treatment of Latent Tuberculosis Infection on QuantiFERON-TB Gold Assay ResultsPOLLOCK, Nira R; KASHINO, Suely S; NAPOLITANO, Danielle R et al.Infection control and hospital epidemiology. 2009, Vol 30, Num 4, pp 392-395, issn 0899-823X, 4 p.Article

Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasisCOLER, Rhea N; SKEIKY, Yasir A. W; BERNARDS, Karen et al.Infection and immunity. 2002, Vol 70, Num 8, pp 4215-4225, issn 0019-9567, 11 p.Article

Potent stimulation of the innate immune system by a Leishmania brasiliensis recombinant proteinBORGES, Monamaris M; CAMPOS-NETO, Antonio; SLEATH, Paul et al.Infection and immunity. 2001, Vol 69, Num 9, pp 5270-5277, issn 0019-9567Article

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisNASCIMENTO, Evaldo; FERNANDES, Demetrios F; PINE, Samuel O et al.Vaccine. 2010, Vol 28, Num 40, pp 6581-6587, issn 0264-410X, 7 p.Article

T-cell expression cloning of Porphyromonas gingivalis genes coding for T helper-biased immune responses during infectionGONCALVES, Reginaldo B; LESHEM, Onir; BERNARDS, Karen et al.Infection and immunity. 2006, Vol 74, Num 7, pp 3958-3966, issn 0019-9567, 9 p.Article

Expression and purification of immunologically reactive DPPD, a recombinant Mycobacterium tuberculosis skin test antigen, using Mycobacterium smegmatis and Escherichia coli host cellsLIU, Chao; FLAMOE, Eric; CHEN, Hong-Jing et al.Canadian journal of microbiology. 2004, Vol 50, Num 2, pp 97-105, issn 0008-4166, 9 p.Article

Initiation of Acquired Immunity in the Lungs of Mice Lacking Lymph Nodes after Infection with Aerosolized Mycobacterium tuberculosisKASHINO, Suely S; VALLERSKOG, Therese; MARTENS, Gregory et al.The American journal of pathology. 2010, Vol 176, Num 1, pp 198-204, issn 0002-9440, 7 p.Article

Th1 biased response to a novel Porphyromonas gingivalis protein aggravates bone resorption caused by this oral pathogenLESHEM, Onir; KASHINO, Suely S; GONCALVES, Reginaldo B et al.Microbes and infection. 2008, Vol 10, Num 6, pp 664-672, issn 1286-4579, 9 p.Article

Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41SKEIKY, Yasir A. W; ALDERSON, Mark R; OVENDALE, Pamela J et al.Vaccine. 2005, Vol 23, Num 30, pp 3937-3945, issn 0264-410X, 9 p.Article

Immunotherapy for drug-refractory mucosal leishmaniasisBADARO, Roberto; LOBO, Iza; MUNOS, Alvaro et al.The Journal of infectious diseases. 2006, Vol 194, Num 8, pp 1151-1159, issn 0022-1899, 9 p.Article

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL® adjuvantSKEIKY, Yasir A. W; COLER, Rhea N; BRANNON, Mark et al.Vaccine. 2002, Vol 20, Num 27-28, pp 3292-3303, issn 0264-410X, 12 p.Article

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human diseaseCAMPOS-NETO, Antonio; PORROZZI, Renato; GREESON, Kay et al.Infection and immunity. 2001, Vol 69, Num 6, pp 4103-4108, issn 0019-9567Article

Discordant QuantiFERON-TB Gold Test Results Among US Healthcare Workers With Increased Risk of Latent Tuberculosis Infection : A Problem or Solution?POLLOCK, Nira R; CAMPOS-NETO, Antonio; NARDELL, Edward et al.Infection control and hospital epidemiology. 2008, Vol 29, Num 9, pp 878-886, issn 0899-823X, 9 p.Article

Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasisFUJIWARA, Ricardo Toshio; VALE, André Macedo; BETHONY, Jeffrey Michael et al.Veterinary research (Print). 2005, Vol 36, Num 5-6, pp 827-838, issn 0928-4249, 12 p.Article

Cloning and characterization of a gene encoding an immunoglobulin-binding receptor on the cell surface of some members of the family TrypanosomatidaeCAMPOS-NETO, Antonio; SUFFIA, Isabelle; CAVASSANI, Karen A et al.Infection and immunity. 2003, Vol 71, Num 9, pp 5065-5076, issn 0019-9567, 12 p.Article

Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime®) and the recombinant Leish-110f® + MPL-SE® vaccine to treat canine visceral leishmaniasisMIRET, Jorge; NASCIMENTO, Evaldo; CAMPOS NETO, Antonio et al.Vaccine. 2008, Vol 26, Num 12, pp 1585-1594, issn 0264-410X, 10 p.Article